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Abstract

Problem Adolescents are contracting sexually transmitted infections (STIs) with half of
all new STIs occurring in those aged 15-24 years old. The American Academy of
Pediatrics, recommended all sexually active adolescents be screened for STIs.
Incorporation of a sexual behavior assessment may assist providers with identifying STI
risk.
Methods A descriptive design comparing three cohorts of adolescents presenting for a
well-exam. The cohorts analyzed were: urine screening on all adolescents, urine
screening for only those reporting sexual activity, and a self-administered sexual history
questionnaire tool, based on the HEEADSSS psychosocial assessments.
Results The majority (97%), of all three cohorts (N=60), had a documented sexual
history in the medical record. A chi-square analysis between cohort one and two (n=49)
comparing sexual history and urine STI testing (χ2 = 5.72, p = .057), and comparing urine
STI testing with a positive urine test (χ2 = 0.04, p = .837) was essentially unremarkable.
A statistical analysis could not be conducted comparing cohort three with cohort one or
cohort two due to incomplete sampling. Overall, about 20% tested positive for an STI
when screened routinely or if the adolescent reported sexual activity.
Implications For Practice Urine screening for STI improved the identification of an STI
in adolescents and is of clinical significance. Assessment of sexual activity and STI risk
may be improved when private time between the adolescent and provider are available, or
through a paper assessment tool completed by the adolescent without a parent present.
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Screening For Sexually Transmitted Infections In Adolescents
Because of high-risk behaviors, adolescents are at an increased risk of exposure to
sexually transmitted infections (STIs). According to the Centers for Disease Control and
Prevention (CDC), youth aged 15-24 years old account for half of the 20 million new
STIs occurring in the US each year (CDC, 2017). Chlamydia trachomatis (chlamydia)
and Neiserria gonorrhoae (gonorrhea) are the most common STIs reported in the
adolescent population (CDC, 2017). The 2017 STI Surveillance Report, reported 62% of
chlamydia infections where diagnosed in those aged 15-24 years old (CDC, 2017).
Additionally, the CDC (2017) reported the rate of gonorrhea infections increased by 15%
between 2016 and 2017 in the adolescent population. Hence, adolescents are engaging in
high-risk sexual behaviors and contracting STIs at an alarming rate.
Despite these facts, STI screenings in the adolescent population may be
inconsistent within the primary care setting. Many adolescents are reluctant to disclose
sexual activity to their medical providers. Adolescents may be accompanied by a
caregiver and the opportunity for time alone with providers is limited or nonexistent,
concerns about confidentiality, and perceived stigma are all associated with adolescents’
failure to disclose sexual activity (Cuffe, Newton-Levinson, Gift, McFarlane, &
Leichliter, 2016). For these reasons and more, testing for STIs, early treatment, and
education for risk reduction are delayed. When left untreated, STIs can lead to long-term
complications such as pelvic inflammatory disease and infertility (AAP, 2014). Primary
care providers have an opportunity to influence the sexual and reproductive health of
adolescents.
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The American Academy of Pediatrics (AAP) publication, Bright Futures
Guidelines for Health Supervision of Infants, Children, and Adolescents, recommended
screening for chlamydia and gonorrhea in all sexually active teens (AAP, 2017). A
comprehensive psychosocial screening tool, the HEEADSSS (Home, Education, Eating,
Activities, Drugs and Alcohol, Suicide and Depression, Sexuality and Safety) assessment,
contains interview questions to assist providers in collecting a psychosocial history of the
adolescent, including sexuality (Smith & McGuinness, 2017). This psychosocial
assessment framework was first introduced by pediatrician Dr. Henry S. Berman in the
1970s. Over time, the evaluation questions have evolved to reflect current risk factors
that affect the adolescent population and to help providers address psychosocial issues in
a confidential and unbiased manner (Smith & McGuinness, 2017).
Testing for chlamydia and gonorrhea can be done easily using nucleic acid
amplification tests (NAATs). NAATs have a high sensitivity and specificity for detecting
these infections (AAP, 2017). Specimens can be collected through urine sample, urethral,
vaginal, and/or cervical swabs. In the pediatric population, urine collection is the least
invasive method, easily obtained, and less intimidating. Gonorrhea and chlamydia can
usually be ordered as a combined test and completed on a single specimen (AAP, 2017).
The AAP recommended all sexually active adolescents receive chlamydia and gonorrhea
testing annually (AAP, 2017).
Current practice at a Midwestern, suburban, organizationally-owned pediatric primary
care office is to collect adolescent sexual histories with parents at the bedside. In general,
adolescents are not given private time with providers which may influence disclosure of
high-risk behavior. At one time, a urine chlamydia or gonorrhea diagnostic test had been
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performed on all adolescents, and at another time the urine test was reserved for those
who had disclosed active sexual activity. The purpose of this quality improvement
initiative was to assess for STI risk by implementing a self-administered sexual history
questionnaire tool, based on the HEEADSSS psychosocial assessment, and perform a
reflexive urine test if sexual risk was indicated. The primary aim was to improve STI
screening and urine testing for adolescents at high risk within the practice. The questions
of study were: During a well-child exam in adolescents aged 13-17 years,
1. What was the overall number of adolescents seen for a well-child exam from
February-March 2018 (cohort one), August-September 2018 (cohort two), and
February-March 2019 (cohort three)?
2. What was the number of those screened for an STI with a urine chlamydia and
gonorrhea diagnostic test from February through March 2018 (cohort one)?
3. What is the number of those screened for an STI with a urine chlamydia and
gonorrhea diagnostic test only when sexual activity was disclosed from August
through September 2018 (cohort two)?
4. Of those screened with a urine chlamydia and gonorrhea test in cohort one and
cohort two in 2018, how many tested positive for one or both diseases?
5. What was the number of those screened with the modified HEEADSSS
questionnaire from February through March 2019 (cohort three)?
6. Of those who were screened with the modified HEEADSSS questionnaire in 2019
(cohort three), how many were found to be at risk for an STI?
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7. Of those who were found to be at risk for an STI with the modified HEEADSSS
questionnaire in 2019 (cohort three), how many had a urine chlamydia and
gonorrhea test performed?
8. What was the rate of positive STI infection identified by urine testing between the
three cohorts?
Review of Literature
A systematic literature review included the databases of Summon, PubMed,
CINAHL, Google Scholar, and the Cochrane Library. The key words used were sexually
transmitted infections, adolescents, screenings, primary care, chlamydia, gonorrhea,
HEEADSSS, and psychosocial assessments. The literature review included research
articles and studies from 2008 through 2018. The search was filtered for full text articles
published in English, journal articles, and scholarly peer-reviewed publications. Articles
were excluded if they were not related to the adolescent population, chlamydia
trachomatis, and/or gonorrhea. Ultimately, 14 publications were chosen for this literature
review.
Several organizations have released evidence-based practice guidelines and
recommendations on STI screenings and treatment in adolescents (AAP, 2014; CDC,
2017, US Preventative Services Task Force [USPSTF], 2014). All agreed sexually active
adolescents should be tested annually for chlamydia and gonorrhea. Despite these
recommendations and guidelines, rates of chlamydia and gonorrhea remain highest
among adolescents (CDC, 2017). Hence, opportunities exist in preventative sexual and
reproductive health care that is provided to adolescents.

ADOLESCENT STI SCREENINGS

7

Office visits present opportunities for primary care providers to educate
adolescents on sexual health. Schneider, FitzGerald, Byczkowski, and Reed (2016)
conducted a study in a pediatric emergency department collecting urine samples for
chlamydia and gonorrhea from 403 asymptomatic adolescents with non-genitourinary
complaint. About 10% (n=40) were positive for at least one STI; moreover, about 90% of
the subjects acknowledged having a primary care provider (Schneider et al., 2016).
Because adolescents engage in high-risk sexual behaviors, vigilance in screening,
identifying, and treating STI infections in adolescents in the primary care setting is
recommended (AAP, 2017). While prevention is a primary goal, addressing the sexual
and reproductive health needs of adolescents cannot be ignored (AAP, 2017).
Sexual activity is common in adolescence. Goyal, Witt, Hayes, Zaoutis, & Gerber
(2014) conducted a study on clinical providers screening adolescents for sexual activity
and STIs. Their study was conducted across 29 pediatric primary care offices and
included a retrospective cross-sectional study of randomly selected adolescents, aged 13to 19-years (Goyal et al., 2014). From 1,000 well-child encounters reviewed, only 21%
(n=212) of adolescents had a documented sexual history and 21% (n=45) of those
adolescents were identified as being sexually active; however, only 33% (n=15) of the
adolescents documented as sexually active received testing for chlamydia and gonorrhea
(Goyal et al., 2014). Goyal et al. (2014) found greater than 50% of the sexually active
adolescents in their study did not get recommended STI testing. Additionally, nearly 80%
of adolescent well-child visits reviewed did not have a sexual history documented (Goyal
et al., 2014). Thus, when sexual histories are unknown, a missed opportunity for STI
testing exists, and appropriate treatment does not occur.
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Adolescents may feel invincible about acquiring an STI. Cuffe et al. (2016)
surveyed over 3,000 adolescents and found 11.5% reported receiving an STI test in the
last 12 months, and 34% reported having an STI test as part of their routine health visit.
Of those sexually active and never tested, 41.8% did not seek testing on their own
because of believing they were not at risk for an STI (Cuffe et al., 2016). Some
adolescents (32.5%) reported not seeking STI testing because their medical provider did
not suggest it (Cuffe et al., 2016). Adolescents may be influenced to be tested for an STI
when a medical provider recommends it. Early identification of an STI may result in
early treatment thereby preventing long-term sequelae.
Several barriers exist to adolescent STI screening and understanding them may
clarify why there is a lack of screening and testing in this population. The largest barrier
in preventing an adolescent from disclosing sexual activity and seeking STI screening,
may be related to their concerns of confidentiality (Cuffe, Newton-Levinson, Gift,
McFarlane, & Leichliter, 2016; Fuentes, Ingerick, Jones, & Lindberg, 2018; Marcell, &
Burstein, 2017). Adolescents may fear adult judgement. To minimize confidentiality
concerns, recommendations included using psychosocial assessment tools that screen for
high-risk behaviors specifically addressing sexual activity (Bradford & Rickwood, 2012).
Furthermore, screening tools conducted through private interview, pen/paper assessment
tools, and technology devices on tablets and iPads were recommended (Bradford &
Rickwood, 2012).
Respecting confidentiality gains trust from an adolescent. Kadivar et al. (2014)
demonstrated adolescents were more likely to answer screenings with more honesty when
done confidentially. In a systematic review by Bradford and Rickwood (2012), self-
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administered tools were found to be the most accepted amongst adolescents, and their use
improved engagement with the healthcare provider. Despite confidential screening with a
self-administered tool, some practitioners did not complete follow-up with the adolescent
on potential risks (Bradford & Rickwood, 2012).
The use of validated, standardized screening instruments can be beneficial for
increasing the effectiveness of the care provided in busy primary care practices. Eade and
Henning (2013) found the use of a comprehensive youth assessment tool, such as the
HEADSS assessment tool, facilitated STI screenings. In their study, 85 adolescents had
completed a HEADSS assessment with half (n=43) of the adolescents being screened for
chlamydia due to identified risk, resulting in 25% (n=11) of them having a positive result
(Eade & Henning, 2013). Incorporating high-risk behavior assessment tools may assist
providers with education, testing, and treatment needed to improve health care for
adolescents.
The framework to guide this clinical scholarship project was based on the
Donnebedian model of structure, process, outcomes. Specifically, the Plan-Do-Study-Act
(PDSA) was selected. The PDSA cycle is a four-step model for improving a process. The
“plan” phase of this cycle involves developing a test for change. The “do” phase of this
model is to implement the plan and document data. The “study” phase is to evaluate the
data and determine if the plan was beneficial. The “act” phase involves adopting,
adapting, and/or adjusting the intervention (Christoff, 2018). The PDSA is the most
commonly used tool in healthcare quality improvement (Christoff, 2018). Utilizing the
PDSA cycle to implement change has resulted in significant improvements in care and
patient outcomes (Christoff, 2018).
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Design
An observational, descriptive, cohort design was utilized. The PDSA cycle to test
the change of implementing a modified HEEADSSS assessment was done. The modified
HEEADSSS assessment implementation began in February and ended in March 2019. In
addition, a retrospective medical record review was done from February-March 2018,
August-September 2018, and February-March 2019 to assess the effectiveness of
screening all adolescents, screening only those who disclose sexual activity, and
screening those who indicate sexual activity on a written assessment. A chlamydia and
gonorrhea urine diagnostic test was used to compare results for identifying adolescents at
risk for and/or who had an STI.
Setting
An organizationally-owned, pediatric primary care office located in a Midwestern
suburb of a metropolitan area was selected for this study. This practice provided pediatric
primary care services as well as behavioral health therapy services. Care was provided to
those aged 0- through 18-years old. The practice consisted of two pediatricians, one
pediatric nurse practitioner, one clinical social worker, three medical assistants, and two
staff nurses. According to the most recent census, the estimated population of the service
area is 41,649 with nearly 28% of the population being under 18 years of age (U.S.
Census Bureau, 2017). Caucasians represent 69% of the population, African Americans
25%, Latinos 2%, and other races representing less than 1% (U.S. Census Bureau, 2017).
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Sample
A retrospective record review was conducted on a convenience sample of
adolescents during a well-child visit during three different periods in time. There were
three cohorts: Cohort 1 representing practice with urine screening for STI was done on all
adolescents, Cohort 2 representing practice with urine screening for STI was only done
on adolescents reporting to be sexually active, and Cohort 3 representing practice
utilizing a modified HEEADSSS assessment tool and a reflexive urine screening for STI.
Inclusion criteria was 13-17 years of age; able to read, understand, and answer questions
on the questionnaire; and scheduled for a well-child visit. Exclusion criteria was less than
13- or greater than 17-years of age; unable to read, understand, and/or answer questions
on a questionnaire.
Procedures
A team of key stakeholders was formed and included the site manager, staff
pediatric nurse practitioner, and medical assistants. After review and discussion of the
current STI screening process, the modified HEEADSSS assessment was selected as the
additional screening tool and if positive, a reflexive urine test would be performed. A
modified HEEADSSS assessment was offered at the beginning of the visit to those who
met inclusion criteria; however, the adolescent had the choice to complete (or not) the
pen/paper assessment on their own. If completed, the modified HEEADSSS assessment
was reviewed by the medical provider. If the questionnaire was found to indicate sexual
activity or risk for STI, a chlamydia and gonorrhea urine diagnostic test was ordered.
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Data Collection & Analysis
All data was retrieved from a retrospective medical record review. Demographic
data included age, gender, and race/ethnicity. Additional data included a modified
HEEADSSS assessment completion, urine diagnostic testing completion, and urine
diagnostic testing results. Data was stored and collected on a password-protected
computer and flash drive. All personal identifiers were removed and data was coded as
18-1, 18-2, 18-3, etc. and 18-1a, 18-2a, 18-3a, etc. for those records reviewed from 2018.
In addition, 19-1, 19-2, 19-3, etc., for those records reviewed in 2019. Data was analyzed
using descriptive and chi-square statistics.
Approval Processes
Administrative approval for project implementation was obtained from the
pediatric primary care practice. Approvals from the doctor of nursing practice (DNP)
committee, institutional review board (IRB), and graduate school from the University
were obtained. There was minimal to no risk to the adolescents as this was retrospective
medical record review. Parental consent was not needed due to state law requirements of
those 12-years and older not needing parental permission to authorize health care services
for the diagnosis and/or treatment of STIs (410 ILCS 210/4). Benefits of STI screening of
adolescents included early identification and treatment of STIs.
Results
A retrospective medical record review was conducted with three cohorts (N=60):
(1) February – March 2018 (representing practice with urine screening for STI on all
adolescents), (2) August – September 2018 (representing practice with urine screening
for STI only on adolescents reporting to be sexually active), and (3) February – March
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2019 (representing practice utilizing a modified paper HEEADSSS assessment tool and
reflexive urine screening for STI). In the first cohort, 16 adolescent medical records were
reviewed (n=16). The age of the adolescent ranged from 13- to 17-years, with a mean age
of 15 (sd=1.5) years with the most frequently occurring age being 13-years. Of these 16
adolescents, 56% were female (n = 9) and 44% were male (n=7). Adolescent
race/ethnicity were White (n = 7, 44%), Black (n=6, 37%), and Hispanic (n=3, 19%) in
this cohort. All adolescents had a sexual history documented by the provider (n = 16).
Just over 6% (n=1) were documented as being sexually active, 87.5% (n=14) were
documented as not being sexually active, and 6% (n=1) neither reported nor denied
sexual activity. Nearly 56% (n=9) of the adolescents had a urine screen for STI
completed while 44% (n=7) did not. Of the nine urine screens, 22% (n=2) had urine
testing positive for an STI (Appendix A).
In the second cohort, 33 medical records were reviewed (n=33). The age of the
adolescent ranged from 13- to 17-years, with a mean age of 15 (sd=1.2) years with the
most frequently occurring age being 14-years. Of these 33 adolescents, 45% were female
(n = 15) and 55% were male (n=18). Adolescent race/ethnicity were White (n = 10,
30%), Black (n=17, 52%), Hispanic (n=4, 12%), and Other (n=2, 6%) in this cohort.
Nearly 94% of these adolescents had a sexual history documented by the provider (n =
31) while two (6%) did not. Only 15% (n=5) were documented as being sexually active,
79% (n=26) were documented as not being sexually active, and 6% (n=2) neither
reported nor denied sexual activity. Nearly 84% (n=5) of the adolescents had a urine
screen for STI completed while one (17%) did not. Of the five urine screens, 20% (n=1)
had urine testing positive for an STI (Appendix B).
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The combination of cohorts one and two (n=49) represent the comparison sample
for the effectiveness of the HEEADSSS assessment and reflexive urine screening for STI.
Within these first two cohorts, the age of the adolescent ranged from 13- to 17-years,
with a mean age of 15 (sd=1.3) years with the most frequently occurring age being 14years. Of these 49 adolescents, 49% were female (n = 24) and 51% were male (n=25).
Adolescent race/ethnicity were White (n = 17, 35%), Black (n=23, 47%), Hispanic (n=7,
14%), and Other (n=2, 4%) in this sample. Nearly 94% of these adolescents had a sexual
history documented by the provider (n = 46) while three (6%) did not. Only 12% (n=6)
were documented as being sexually active, 82% (n=40) were documented as not being
sexually active, and 6% (n=3) neither reported nor denied sexual activity. Nearly 29%
(n=14) of the adolescents had a urine screen for STI completed while 71% (n=35) did
not. Of the 14 urine screens, 21% (n=3) had urine testing positive for an STI and nearly
79% (n=22.5) were negative for STI (Appendix C).
The third cohort represented HEEADSSS assessment and a reflexive STI urine
screen (n=11) for which the combined first two cohorts were compared. Within this
cohort, the age of the adolescent ranged from 13- to 17-years, with a mean age of 15
years (sd=1.5) years with the most frequently occurring age being 14-years. Of these 11
adolescents, 36% were female (n=4) and 64% were male (n=7). Adolescent
race/ethnicity were White (n = 1, 9%), Black (n=9, 82%), and Hispanic (n=1, 9%). All 11
of these adolescents had a sexual history documented by the provider that was collected
using the modified HEEADSSS assessment tool on a paper document. Only 9% (n=1)
reported being sexually active, 90% (n=10) reported not being sexually active. One
adolescent had a urine screen for STI ordered while 90% (n=9) did not (Appendix D).
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A chi-square test was conducted on the combinations of cohort one and two
(n=49) to compare sexual history and STI urine testing. There was no statistical
difference between the samples regarding the rate of STI urine screening on all
adolescents when compared to urine screening on only those who disclosed sexual
activity (χ2 = 5.72, p = .057) (Appendix E). A second chi-square test was conducted with
the same cohorts’ comparing the rate of STI urine testing and those testing positive on the
urine test. There was no difference in the rate of urine testing positive between those who
were automatically screened and those who were screened only if sexual activity was
disclosed (χ2 = 0.04, p = .837) (Appendix F). A statistical analysis could not be conducted
between cohort three with cohort one or cohort two due to the lack of urine results for the
third cohort.
Discussion
There were 60 adolescent well-child visits during the selected periods of study
with an average age of 15-years. The first cohort resulted in 16 patients for whom STI
urine screening was routine for all adolescent patients regardless of the report of sexual
activity. The second cohort resulted in 33 patients where STI urine screening was only
performed on those reporting sexual activity. Finally, the third cohort resulted in 11
patients screened with the modified HEEADSSS assessment and reflexive STI urine
screen.
All three cohorts demonstrated a majority (97%) of adolescent patients had a
documented sexual history in the medical record during the study periods and is clinically
significant. Because the practice did not typically provide private time between the
provider and the adolescent, most adolescents denied sexual activity (83%). In addition,
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all STI risk assessments and sex histories were performed with the parents at the bedside.
In the first cohort, all patients had a sexual history documented with nearly 88% denying
sexual activity, one reported sexual activity, and one neither reported nor denied sexual
activity. However, two of the adolescents who denied sexual activity had a positive urine
screen for chlamydia. In the second cohort, nearly 79% denied sexual activity, 15%
reported sexual activity, and two patients neither reported or denied sexual activity.
Finally, nearly all adolescents screened with the HEEADSSS assessment and reflexive
STI urine screen in the third cohort denied being sexually active. Hence, most
adolescents denied sexual activity when caregivers were present. Sexual activity and STI
risk may have been more accurately identified if confidential, private time between the
adolescent and provider were available. Furthermore, a paper assessment tool or
technology device provided to and completed by the adolescent without a parent present
may have provided some privacy for the adolescent.
During the study period for the first cohort when all adolescents were to have a
STI urine screen, just over half of the patients (n=9, 56%) completed the diagnostic test.
Of the STI urine screens in this cohort, 22% (n=2) tested positive for chlamydia or
gonorrhea. In the second cohort when adolescents were to have a STI urine screen if they
reported being sexually active, 100% (n=5) had the diagnostic test completed. Of those,
20% (n=1) of the five, tested positive for chlamydia. In the third cohort, 9% (n=1)
screened positive for STI risk with the HEEADSSS assessment. This patient did have a
urine sample ordered and collected, however, the specimen was not sent to the lab for
testing due to miscommunication between the provider and the medical assistant. Overall,
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it appeared about one in five (20%) had tested positive for an STI when screened
routinely or if the adolescent reported sexual activity and is of clinical significance.
Several limitations were identified in this study. The first limitation was the
sample size. Only 11 adolescents were screened with the modified HEEADSSS
assessment with one reflexive urine test that was ordered and collected, but not resulted.
This made it difficult to determine the effectiveness of utilizing this for screening and
determining if urine testing was needed. Also, the modified HEEADSSS screening was
only conducted by the pediatric nurse practitioner. With only one provider in the practice
using this screening tool, the sample may not have been representative of the entire
practice. Another limitation was the urine sample obtained reflexively after the
HEEADSSS assessment was ordered and collected but never resulted. No determination
could be made between screening with the modified HEEADSSS assessment and
reflexive urine testing as an alternative to the routine screening of all adolescents.
Recommendations for further study include a larger sample size and the impact of
age on reported sexual activity. While most patients denied sexual activity, the effect of
age on sexual activity and rate of STI may be of interest. Regardless, the routine STI
urine screening and STI urine screening only if sexual history was reported resulted in the
identification of 20% of adolescents having an STI. The modified HEEADSSS
assessment with a reflexive STI urine screen was unable to be determined as effective in
identifying those who may have had an STI; therefore, more study is needed.
An implication for practice includes urine testing for STI to identify the presence
of STI in some adolescents regardless of their sexual activity disclosures. Perhaps the
availability of a urine sample before the provider has verbally screened the patient for
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STI risk may aid in the completion of a STI urine screen when ordered. Finally, when
sexual histories are obtained, STI risk may be better assessed if the parent or caregiver
are asked to leave the room. The AAP (2017) recommended privacy when providing
medical care to adolescents and to begin preparing pre-teens and parents on changes to
the visit during the 12-year old well child visit.
Conclusion
In summary, most of the adolescent patients undergoing a well-child exam had a
sexual history documented and nearly 1/5 of those adolescents tested positive for STI.
While the effects of screening using a modified HEEADSSS assessment with reflexive
STI urine screen were unable to be obtained in this study, screening of some sort
improves the identification of STI. The identification of adolescents having an STI may
enhance early treatment and delay or eradicate long-term consequences occurring from
an STI. Ideally, best practice is to obtain sexually histories without caregivers at the
bedside. This promotes disclosure and can aid in identification of STI risk.
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Table 1
STI Urine Screen For All Adolescents (Cohort One)
Variable
Documented Sexual History
Yes
Reported or Denied Sexual Activity
Denied
Neither Reported Nor Denied
Reported
STI Testing Done
Yes
No
Positive Urine Test
Yes
No
Race
Black
White
Hispanic
Gender
Female
Male

Variable
Age

M
14.81

SD
1.47

n

%

Cumulative %

16

100

100

14
1
1

87.50
6.25
6.25

87.50
93.75
100

9
7

56.25
43.75

56.25
100

2
7

22.22
77.78

22.22
100

6
7
3

37.50
43.75
18.75

37.50
81.25
100

9
7

56.25
43.75

56.25
100

n
16

Mdn
15.00

Mode
13.00
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Table 2
STI Urine Screen Only For Adolescents Reporting Sexual Activity (Cohort Two)
Variable
Documented Sexual History
Yes
No
Reported or Denied Sexual Activity
Denied
Reported
Neither Reported Nor Denied
STI Testing Done
Yes
No
Positive Urine Test
No
Yes
Race
White
Black
Hispanic
Other
Gender
Male
Female

Variable
Age

M
15.06

SD
1.20

n

%

Cumulative %

31
2

93.94
6.06

93.94
100

26
5
2

78.79
15.15
6.06

78.79
93.94
100

5
1

83.33
16.67

83.33
100

4
1

80
20

80
100

10
17
4
2

30.30
51.52
12.12
6.06

30.30
81.82
93.94
100

18
15

54.55
45.45

54.55
100

n
33

Mdn
15.00

Mode
14.00
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Table 3
Cohort One and Two Combined
Variable
Documented Sexual History
Yes
No
Reported or Denied Sexual Activity
Denied
Neither Reported Nor Denied
Reported
STI Testing Done
Yes
No
Positive Urine Test
Yes
No
Gender
Female
Male
Race
Black
White
Hispanic
Other

Variable
Age

M
14.98

SD
1.28

n

%

Cumulative %

46
3

93.88
6.12

93.88
100

40
3
6

81.63
6.12
12.24

81.63
87.76
100

14
35

28.57
71.43

28.57
100

3
11

21.43
78.57

21.43
100

24
25

48.98
51.02

48.98
100

23
17
7
2

46.94
34.69
14.29
4.08

46.94
81.63
95.92
100

n
49

Mdn
15.00

Mode
14.00
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Table 4
STI Urine Screen For Adolescents Reporting Sexual Activity On HEEADSSS (Cohort
Three)
Variable
Documented Sexual History
Yes
Reported or Denied Sexual Activity
Denied
Reported
STI Testing Done
No
Yes
Race
White
Black
Hispanic
Gender
Male
Female

Variable
Age

M
14.55

SD
1.51

n

%

Cumulative %

11

100

100

10
1

90.91
9.09

90.91
100

10
1

90.91
9.09

90.91
100

1
9
1

9.09
81.82
9.09

9.09
90.91
100

7
4

63.64
36.36

63.64
100

n
11

Mdn
14.00

Mode
13.00
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Figure 1. Chi-square Test of Cohort 1 and 2 – reported sexual activity & STI testing
completed
Reported or Denied Sexual Actvitiy by STI Testing
35
30
30

Frequency

25

20

15
10
10

5

4

3

2

0
0
STI Testing
No STI Testing

Denied Sexual Activity
10
30

Reported or Denied Sexual Activity
Denied
Neither Reported or Denied
Reported

Neither Reported or Denied
0
3

STI Testing Done
Yes
No
10[11.43]
0[0.86]
4[1.71]

30[28.57]
3[2.14]
2[4.29]

Reported Sexual Activity
4
2

2

χ
5.72

df

p

2

.057
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Figure 2. Chi-square Test of Cohort 1 and 2 – reported sexual activity & positive urine
test
Reported or Denied Sexual Activity by Positive Urine Test
9

8
8

7

Frequency

6

5

4

3
3

2
2

1
1

0

Positive STI Urine Test
Negative STI Urine Test

Denied Sexual Activity
2
8

Reported or Denied Sexual Activity
Denied
Reported

Reported Sexual Activity
1
3

Positive Urine Test
Yes
No
2[2.14]
8[7.86]
1[0.86]
3[3.14]

2

χ
0.04

df
1

p
.837

